Molecular characterization of TEM- and SHV-derived extended-spectrum beta-lactamases in hospital-based Enterobacteriaceae in Turkey

Japanese Journal of Infectious Diseases

Volumn 58, Issue 3, 2005, Pages 162-167

  Taşli, Hüseyin ^a,b   Bahar, I Hakki ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b EGE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; BETA LACTAMASE; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; IMIPENEM; STREPTOMYCIN;

ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; DNA SEQUENCE; ENTEROBACTERIACEAE; HOSPITAL; ISOELECTRIC FOCUSING; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR DYNAMICS; NONHUMAN; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TURKEY (REPUBLIC); ANTIBIOTIC RESISTANCE; DRUG EFFECT; ENTEROBACTER INFECTION; ENZYMOLOGY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; TURKEY;

EID: 23844448752     PISSN: 13446304     EISSN: 13446304     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Bush, K. (2001): New β-lactamases in Gram-negative bacteria, diversity and impact on selection of antimicrobial therapy. Clin. Infect. Dis., 32, 1085-1089.
2. Livermore, D. M. (1995): β-lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev., 8, 557-584.
3. Jacoby, G. A. (1994): Genetics of extended-spectrum beta-lactamases. Eur. J. Clin. Microbiol. Infect. Dis., 13, Suppl. 1, 2-11.
4. Bush, K., Jacoby, G. A. and Medeiros, A. A. (1995): A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother., 39, 1211-1233.
5. Bradford, P. A. (2001): Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev., 14, 933-951.
6. Gur, D., Gultekin, M., Ogunç, D., Gulay, Z., Yulug, N., Sumerkan, B,, Korten, V., Mulazimoglu, L., Gunaydin, M. and Leblebicioglu, H. (1999): Comparative in vitro activity of piperacillin-tazobactam against gram-negative nosocomial pathogens. The 21st International Congress of Chemotherapy, 4-7 July, Birmingham, UK.
7. Bush, K. (1996): Is it important to identify extended-spectrum beta-lactamase-producing organisms? Eur. J. Clin. Microbiol. Infect. Dis., 15, 361-364.
8. MacKenzie, F. M. and Gould, I. M. (1998): Extended spectrum β-lactamases. J. Infect., 36, 255-258.
9. Mabilat, C. and Goussard, S. (1993): PCR detection and identification of genes for extended-spectrum β-lactamases. p. 553-559. In D. H. Persing, T. F. Smith, T. C. Tenover and T. J. White (eds.), Diagnostic Molecular Microbiology. American Society for Microbiology, Washington, D.C., USA.
10. Arlet, G. G., Brami, D., Dércè, A., Flippo, A., Gaillot, O., Lagrange, P. H. and Philippon, A. (1995): Molecular characterization by PCR-restriction fragment length polymorphism of TEM β-lactamases. FEMS Microbiol. Lett., 134, 203-208.
11. Chanawong, A., M'Zali, F. H., Heritage, J., Lulitanond, A. and Hawkey, P. M. (2000): Characterization of extended-spectrum β-lactamases of the SHV family using a combination of PCR-single strand conformational polymorphism (PCR-SSCP) and PCR-restriction fragment length polyrmorphism (PCR-RFLP). FEMS Microbiol. Lett., 184, 85-89.
12. M'Zali, F. H., Gascoyne-Binzi, D. M., Heritage, J. and Hawkey, P. M. (1996): Detection of mutations conferring extended-spectrum activity on SHV β-lactamases using polymerase chain reaction single strand conformational polymorphism (PCR-SSCP). J. Antimicrob. Chemother., 37, 797-802.
13. M'Zali, F. H., Heritage, J., Gascoyne-Binzi, D. M., Snelling, A. M. and Hawkey, P. M. (1998): PCR single strand conformational polymorphism can be used to detect the gene encoding SHV-7 extended-spectrum β-lactamase and to identify different SHV genes within the same strain. J. Antimicrob. Chemother., 41, 123-125.
14. SHV genes. Antimicrob. Agents Chemother., 43, 2960-2963.
15. Garcia-Rodriguez, J. A., Jones, R. N. and MYSTIC Programme Study Group (2002): Antimicrobial resistance in gram-negative isolates from European intensive care units: data from the meropenem yearly susceptibility test information collection (MYSTIC) programme. J. Chemother., 14, 25-32.
16. Kocazeybek, B. S. (2001): Antimicrobial resistance surveillance of gram-negative bacteria isolated from intensive care units of four different hospitals in Turkey. Evaluation of prevalence of extended-spectrum and inducible beta-lactamases using different E-test strips and direct induction methods. Chemotherapy, 47, 396-408.
17. Leblebicioglu, H., Gunaydin, M., Esen, S., Tuncer, I., Findik, D., Ural, O., Saltoslu, N., Yaman, A., Tasova, Y. and Study Group (2002): Surveillance of antimicrobial resistance in gram-negative isolates from intensive care units in Turkey. J. Chemother., 14, 140-146.
18. National Committee for Clinical Laboratory Standards (2000): Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard M7-A5 and informational supplement M100-S10, NCCLS, Wayne, Pa, USA.
19. Jarlier, V., Nicolas, M. and Fournier, G. (1988): Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis., 10, 867-878.
20. Thomson, K. S. and Sanders, C. C. (1992): Detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae: Comparison of the double-disk and three-dimensional tests. Antimicrob. Agents Chemother., 36, 1877-1882.
21. Amyes, S. G. B. and Gould, I. M. (1984): Trimethoprim resistance plasmids in faecal bacteria. Ann. Microbiol., 135B, 177-186.
22. Kado, C. I. and Liu, S. T. (1981): Rapid procedure for detection and isolation of large and small plasmids. J. Bacteriol., 145, 1365-1373.
23. Birnboim, H. C. and Doly, J. (1979): A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res., 7, 1513-1523.
24. Nuesch-Inderbinen, M. T., Hachler, H. and Kayser, F. H. (1996): Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the Etest. Eur. J. Clin. Microbiol. Infect. Dis., 15, 398-402.
25. Livermore, D. M. and Brown, D. F. J. (2001): Detection of β-lactamase-mediated resistance. J. Antimicrob. Chemother., 48, Suppl. 1, 59-64.
26. Gulay, Z., Thomson, C. J., Yulug, N. and Amyes, S. G. (2000): High prevalence of extended spectrum beta-lactamase production among Klebsiella pneumoniae strains isolated at a university hospital in Turkey. J. Chemother., 12, 145-152.
27. Cormican, M. G., Marshall, S. A. and Jones, R. N. (1996): Detection of extended-spectrum β-lactamase (ESBL)-producing strains by the Etest ESBL screen. J. Clin. Microbiol., 34, 1880-1884.
28. Thomson, K. S., Sanders, C. C. and Moland, F. S, (1999): Use of microdilution panels with and without β-lactamase inhibitors as a phenotypic test for β-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens. Antimicrob. Agents Chemother., 43, 1393-1400.
29. Danel, F., Hall, L. M. C., Duke, B., Gur, D. and Livermore, D. M. (1995): OXA-14, another extended-spectrum variant of OXA-10 (PSE-2) β-lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 39, 1881-1884.
30. Danel, F., Hall, L. M. C., Duke, B., Gur, D. and Livermore, D. M. (1999): OXA-17, a further extended-spectrum variant of OXA-10 β-lactamase, isolated from Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 43, 1362-1366.
31. Vahaboglu, H., Dodanli, S., Eroglu, C., Oxturk, R., Soyletir, G., Yildirim, I. and Avkan, V. (1996): Characterization of multiple-antibiotic-resistant Salmonella typhimurium strains: molecular epidemiology of PER-1-producing isolates and evidence for nosocomial plasmid exchange by a clone. J. Clin. Microbiol., 34, 2942-2946.
32. Vahaboglu, H., Ozturk, R., Aygun, G., Coskunkan, F., Yaman, A., Kaygusuz, A., Leblebicioglu, H., Balik, I., Aydin, K. and Oktun, M. (1997): Wide-spread detection of PER-1-type extended-spectrum β-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrob. Agents Chemother., 41, 2265-2269.
33. Paterson, D. L., Hujer, K. M., Hujer, A. M., Yeiser, B., Bonomo, M. D., Rice, L. B., Bonomo, R. A. and the International Klebsiella Study Group (2003): Extended-spectrum β-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type β-lactamases. Antimicrob. Agents Chemother., 47, 3554-3560.
34. Acikgoz, Z. C., Gulay, Z., Bicmen, M., Gocer, S. and Gamberzade, S. (2003): CTX-M-3 extended-spectrum beta-lactamase in a Shigella sonnei clinical isolate: first report from Turkey Scand. J. Infect. Dis., 35, 503-505.
35. Lartigue, M. F., Poirel, L., Héritier, C., Tolün, V. and Nordmann, P. (2003): First description of CTX-M-15-producing Klebsiella pneumoniae in Turkey. J. Antimicrob. Chemother., 52, 315-316.
36. Gulay, Z., Bicmen, M. and Atay, T. (2003): Cefotaximase-M type beta-lactamase production in Escherichia coli isolated at a university hospital in Turkey. 13th Europen Congress of Clinical Microbiology and Infectious Diseases, 10-13 May 2003, Glasgow, UK. Clin. Microbiol. Infect., 9, Suppl., 1, 381.
37. Gur, D., Pitt, T. L., Hall, L. M. C., Akalin, H. E. and Livermore, D. M. (1992): Diversity of Klebsiellae with extended-spectrum β-lactamases at a Turkish university hospital. J. Hosp. Infect., 22, 163-178.
38. Heritage, J., M'Zali, F. H., Gascoyne-Binzi, D. and Hawkey, P. M. (1999): Evolution and spread of SHV extended-spectrum β-lactamase in gram-negative bacteria. J. Antimicrob. Chemother., 44, 309-318.
39. Kim, J., Kwon, Y., Pai, H., Kim, J. V. and Cho, D. T. (1998): Survey of Klebsiella pneumoniae strains producing extended-spectrum β-lactamases: prevalence of SHV-12 and SHV-2a in Korea. J. Clin. Microbiol., 36, 1446-1449.
40. Pai, H., Lyu, S., Lee, J. H., Kim, J., Kwon, Y., Kim, J. W. and Choe, K. W. (1999): Survey of extended-spectrum β-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea. J. Clin. Microbiol., 37, 1758-1763.
41. Perilli, M., Dell'Amico, E., Segatore, B., Masis, M. R. D., Bianchi, C., Luzzaro, F., Rossolini, G. M., Toniolo, A., Nicoletti, G. and Amicosante, G. (2002): Molecular characterization of extended-spectrum β-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey. J. Clin. Microbiol., 40, 611-614.
42. Chanawong, A., M'Zali, F. H., Heritage, J., Lulitanond, A. and Hawkey, P. M. (2001): SHV-12, SHV-5, SHV-2a and VEB-1 extended-spectrum β-lactamases in Gram-negative bacteria isolated in a university hospital in Thailand. J. Antimicrob. Chemother., 48, 839-852.
43. Nuesch-Inderbinen, M. T., Kayser, F. H. and Hachler, H. (1997): Survey and molecular genetics of SHV β-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12. Antimicrob. Agents Chemother., 41, 943-949.